Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis - AcademicCME

Update on Advanced Anti-CD20 Therapeutics to Improve Outcomes for Patients with Multiple Sclerosis

1.0

Claim your AMA PRA Category 1 Credit

Already have an Account? Log In
Don’t have an account? Register Today

Claim your Certificate

course Faculty

No data was found

Related Courses

The Expanding Role of FcRn Blockers to Achieve Minimal Symptom Expression in Patients with...

ASH2025 Update on Management of Anemia in Patients with Myelofibrosis

Revisiting the Safety Record of IL-17 Inhibitors: A Guide for Dermatologists